Immatics appoints Thomas Ulmer as Chief Financial Officer

17. January 2018

|In Portfolio News

|By eazee-designstudio

Immatics today announced the appointment of Thomas Ulmer as Chief Financial Officer, effective April 1st, 2018. Thomas Ulmer joins Immatics from the Merck Group, where he is currently Chief Financial Officer of the Allergopharma Business Unit.